IRLAB Therapeutics
Dedicated to the discovery and development of new drugs for treatment of Parkinson’s disease and other life-altering diseases that affect the central nervous system (CNS).
Market cap
$25.3m
Enterprise value
$23m
Share price
SEK3.92 IRLAB-A.ST
Company register number
556931-4692
Authorizing premium user...